GSK raises guidance
It looks like GSK may have found its blockbuster. Arexvy, the world’s first RSV vaccine for older adults has been approved in the U.S. and Japan.
City Of United Kingdom Infanrix Pediarix Smithkline Beecham Emma Walmsley National Immunization Programs
Source: wfmz.com